📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-28 17:08
453 analysed today
453
Today
133,342
All-time analysed
40,106
Positive
6,279
Negative
79,144
Neutral
7,745
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
39 announcements match the current filters (relevance ≥ 5).
Cupid Receives In-Principle Board Approval for 49% Owned South African Manufacturing Venture
Cupid Limited has secured in-principle board approval to establish a manufacturing venture in South Africa in partnership with a local entity. Under the proposed asset-light structure, Cupid will hold up to a 49% stake and provide technical expertise and quality systems, while the local partner will hold at least 51% and fund all capex and working capital. The facility will manufacture, test, package, and supply male condoms and related products to support participation in South African tenders (such as the RT75-2025 five-year tender) and regional African exports.
Confidence: HIGH
What changedBoard granted in-principle approval to set up a JV manufacturing facility in South Africa with up to 49% equity participation by Cupid.
Why it mattersEnables Cupid to comply with South African domestic manufacturing and procurement criteria for government tenders on an asset-light basis without funding upfront capex.
Cupid proposed stake: up to 49%Local partner proposed stake: at least 51%Target tender participation: RT75-2025 five-year tenderVenture Capex funded by Cupid: Nil (funded by local partner)
📅 Short termPositive sentiment from strategic international footprint expansion and qualification for local South African institutional tenders.
📈 Long termEstablishes a localized African manufacturing hub that can improve win rates in regional healthcare tenders while keeping Cupid's balance sheet asset-light.
⚠ Risk flags
- Execution risk as the venture is currently at the in-principle approval stage pending definitive agreements
- Minority stake (up to 49%) means operational control rests with the local South African partner
- Regulatory and geopolitical risks associated with cross-border African operations
Key Highlights
Board approved an in-principle manufacturing venture in South Africa with a local partner
Cupid to hold up to 49% equity, while the South African partner holds at least 51% to meet local transformation and tender norms
Asset-light structure: Cupid provides technology transfer and operational expertise, while capex and working capital are funded by the local partner
Aims to strengthen participation in the ongoing RT75-2025 5-year tender and expand across African markets
👀 What to Watch
Track definitive agreement execution, capital outlays, facility location/capacity announcements, and formal regulatory approvals in South Africa.
Cupid gets in-principle board approval for South Africa manufacturing JV with up to 49% stake
Cupid Limited's Board has granted in-principle approval to establish a manufacturing venture in South Africa with a local partner to produce male condoms and related products. Cupid will hold up to a 49% equity stake and contribute technical know-how, technology transfer, and quality systems. The South African partner is slated to fund all capex, working capital, and operational requirements. The arrangement is currently at an in-principle stage and remains subject to the execution of definitive agreements.
Confidence: HIGH
What changedCupid's board approved setting up an overseas JV in South Africa where Cupid holds up to 49% equity via tech transfer while the partner funds capex.
Why it mattersEnables asset-light entry into the South African market to satisfy domestic manufacturing and localisation mandates without Cupid deploying heavy upfront capital.
Cupid Proposed Equity Stake: up to 49%Capex Commitment by Cupid: nil (funded by SA partner)TTM Revenue: ₹452 Cr
📅 Short termInformational trigger; stock sentiment may be supported, but concrete impact awaits signing of binding agreements.
📈 Long termIf successfully executed, gives Cupid a local manufacturing footprint in Africa, supporting international institutional and retail order growth with minimal balance sheet leverage.
⚠ Risk flags
- Definitive agreements yet to be finalized and executed
- Execution and regulatory risks in setting up foreign manufacturing operations
Key Highlights
Board approved in-principle plan to establish a male condom manufacturing venture in South Africa
Cupid proposed to hold up to 49% equity share capital in the new entity
Partner to fund entire capital expenditure, working capital, and operational funding
Cupid to provide technology transfer, manufacturing expertise, quality-control systems, and training
Subject to finalisation and execution of definitive agreements
👀 What to Watch
Track subsequent regulatory filings regarding the finalisation of definitive agreements, entity incorporation, commercial timeline, and expected capacity details.
Cupid Q1 FY27 Net Profit Jumps 194% YoY to ₹44.16 Cr; Revenue Up 158% to ₹154.71 Cr
Cupid Limited reported a robust start to FY27, with Q1 revenue from operations surging 158.7% YoY to ₹154.71 Cr. Net profit followed suit, growing 194% YoY to ₹44.16 Cr, driven by strong operational performance and a PBT margin of 38.7%. The company also announced an exploratory manufacturing project in West Bengal for medical devices and healthcare products. Furthermore, Cupid highlighted a strategic investment in Baazar Style Retail Limited through convertible warrants.
Confidence: HIGH
What changedCupid has significantly scaled its quarterly revenue and profitability while initiating a new geographic expansion strategy in West Bengal.
Why it mattersThe massive YoY growth indicates successful execution of the company's strategy to scale B2C FMCG revenue and leverage its dominant market position in sexual wellness.
Q1 FY27 Revenue: ₹154.71 CrQ1 FY27 Net Profit: ₹44.16 CrYoY Revenue Growth: 158.7%YoY Net Profit Growth: 194%Q1 Revenue vs TTM Revenue: 43.3%
📅 Short termThe stock is likely to react positively to the substantial earnings beat and the announcement of a new expansion project.
📈 Long termThe company is transitioning from a niche manufacturer to a broader healthcare and FMCG player, supported by massive capacity expansions and new product lines like IVD kits.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Raw material price volatility (latex/silicon oil)
- Geopolitical risks affecting 52% export revenue
- Execution risk for the new West Bengal project
Key Highlights
Revenue from operations increased 158.7% YoY to ₹154.71 Cr in Q1 FY27 compared to ₹59.80 Cr in Q1 FY26.
Net profit for the quarter rose 194% YoY to ₹44.16 Cr from ₹15.02 Cr in the same period last year.
Board approved an exploratory exercise for a new manufacturing and distribution project in West Bengal.
Strategic investment in Baazar Style Retail Limited via warrants to be converted into equity within 18 months.
Basic EPS for the quarter improved to ₹0.33 from ₹0.11 in the year-ago period.
👀 What to Watch
Investors should monitor the feasibility outcome of the West Bengal project and the progress of the Palava facility capacity boost to 1.25 billion male condoms.
194% YoY PAT Growth; Cupid Upgrades FY27 Revenue Guidance to ₹725-750 Cr
Cupid Limited reported a robust Q1 FY27 with Net Profit surging 194% YoY to ₹44.15 Cr and Operating Income growing 159% YoY to ₹154.72 Cr. Management significantly upgraded its FY27 guidance to ₹725-750 Cr in revenue and ₹210-225 Cr in Net Profit, representing a ~21% increase from the original revenue target. Growth is supported by a 10% price hike in exports and the upcoming commissioning of the Palava facility in Q2 FY27. EBITDA margins expanded sharply to 39%, up from 28% in the previous year's quarter.
Confidence: HIGH
What changedCupid has significantly revised its full-year FY27 financial outlook upwards and reported a massive expansion in operating margins.
Why it mattersThe guidance upgrade indicates strong demand visibility and pricing power, while the upcoming capacity expansion provides the necessary infrastructure to double the company's current revenue scale.
Q1 FY27 Net Profit: ₹44.15 CrRevised FY27 Revenue Guidance: ₹725 Cr - ₹750 CrGuidance vs TTM Revenue: ~203% to 210%EBITDA Margin: 39%Incremental Male Condom Capacity: 770 million units
📅 Short termThe stock is likely to react positively to the substantial guidance upgrade and the 194% jump in bottom-line performance.
📈 Long termThe company is transitioning from a niche B2B player to a larger-scale FMCG and healthcare entity, with capacity set to more than double in FY27.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk for the Palava facility commissioning
- Currency volatility affecting 52% of export-led revenue
- Raw material price sensitivity (latex and silicon oil)
Key Highlights
Net Profit increased 194% YoY to ₹44.15 Cr for the quarter ended June 30, 2026
FY27 Revenue guidance raised to ₹725-750 Cr, more than double the TTM revenue of ₹357 Cr
EBITDA margins expanded by 1,127 basis points YoY to reach 39%
Palava facility on track for Q2 FY27 commissioning, adding 770 million male condom capacity
Implemented a minimum 10% price increase across the export portfolio to improve realizations
👀 What to Watch
Watch for the successful commissioning of the Palava facility in Q2 FY27 and the conversion of the IVD kit pipeline into firm orders from Indian state governments.
194% YoY Profit Growth in Q1 FY27; Board Approves West Bengal Expansion
Cupid Limited reported a robust Q1 FY27 with standalone revenue reaching ₹154.72 Cr, a 158% increase from ₹59.80 Cr in the same quarter last year. Net profit surged 194% YoY to ₹44.16 Cr, maintaining strong momentum from the previous fiscal. The Board has also granted in-principle approval for a new manufacturing project in West Bengal focused on medical devices and healthcare products. Additionally, the company confirmed a strategic investment in Baazar Style Retail Limited through convertible warrants.
Confidence: HIGH
What changedCupid has significantly scaled its quarterly revenue run-rate from ~₹60 Cr to ~₹155 Cr within a year and is now exploring a new geographic manufacturing base in West Bengal.
Why it mattersThe massive growth in top and bottom lines supports the company's high P/E valuation (88.9) and indicates successful execution of its expansion into B2C and high-margin medical devices.
Q1 FY27 Revenue: ₹154.72 CrQ1 FY27 Net Profit: ₹44.16 CrYoY Revenue Growth: 158.7%Q1 FY27 EPS: ₹0.33Revenue vs TTM Revenue: 43.3%
📅 Short termThe stock is likely to react positively to the strong earnings beat and the announcement of a new expansion project, which provides visibility for future growth.
📈 Long termThe shift towards a broader healthcare/medical device portfolio and geographic diversification into West Bengal could structurally de-risk the business from its historical reliance on institutional condom tenders.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- High valuation (P/E 88.9) leaves little room for execution misses
- Execution risk associated with the new West Bengal project
- Raw material price volatility (latex/silicon oil)
Key Highlights
Revenue from operations grew 158.7% YoY to ₹154.72 Cr in Q1 FY27.
Net profit increased 194.1% YoY to ₹44.16 Cr from ₹15.02 Cr in Q1 FY26.
Profit Before Tax (PBT) stood at ₹59.93 Cr, representing a healthy margin of approximately 38.7%.
Board approved an exploratory exercise for a new manufacturing project in West Bengal.
Strategic investment in Baazar Style Retail Limited via warrants to be converted within 18 months.
👀 What to Watch
Monitor the feasibility study and land acquisition timeline for the West Bengal project, as well as the progress of the 1.5x capacity boost at the Palava facility mentioned in previous strategies.
USD 5 Mn Follow-on Investment in GII Healthcare Investment Limited
Cupid Limited has announced an additional USD 5 million (approx. ‡41.75 Cr) follow-on investment in GII Healthcare Investment Limited, a healthcare-focused platform managed by Gulf Islamic Investments (GII). The investment is funded entirely through internal accruals and aims to increase Cupid's participation in the GCC healthcare sector, specifically in Saudi Arabia and the UAE. This follows an initial investment and targets a platform that holds stakes in major providers like Abeer Medical Company and AlMeswak Dental Company. The move represents a strategic diversification of capital into the broader healthcare ecosystem beyond manufacturing.
Confidence: HIGH
What changedCupid has increased its financial commitment to a Middle Eastern healthcare investment platform, deepening its strategic partnership with GII.
Why it mattersThis provides Cupid with indirect exposure to the high-growth Saudi Arabian healthcare market and potentially opens doors for its own product distribution (condoms, IVD kits) through GII's healthcare network.
Investment Value: USD 5 MnInvestment vs TTM Revenue: ~11.7%Investment vs Net Worth: ~9.3%GII Assets Under Management: > USD 3.5 BillionTTM Revenue: ‡357 Cr
📅 Short termThe market may view this as a positive utilization of cash reserves, though the immediate impact on the P&L will be limited until returns from the platform are realized.
📈 Long termThis is a strategic move to diversify revenue streams and build a global healthcare network, complementing Cupid's ongoing 1.5x capacity expansion at its Palava facility.
⚠ Risk flags
- Capital allocation risk into non-core investment platforms
- Geopolitical and regulatory risks in the GCC region
- Currency volatility (USD/INR)
Key Highlights
Additional investment of USD 5 million (approx. ‡41.75 Cr) into the GII healthcare platform.
Investment is 100% funded through internal accruals, reflecting a strong cash position (TTM PAT of ‡108 Cr).
The investment value represents approximately 11.7% of Cupid's TTM revenue of ‡357 Cr.
GII manages assets exceeding USD 3.5 billion across Saudi Arabia, UAE, Europe, USA, and India.
Strategic focus on the GCC healthcare sector, driven by rising insurance penetration and government investment.
👀 What to Watch
Investors should monitor the 'Other Income' or 'Share of Profit from Associates' in future quarterly results to track the financial performance of this investment and watch for any distribution synergies in the GCC region.
₹150 Cr+ Q1 Revenue Target; Cupid Revises FY27 Guidance Upward to ₹660 Cr
Cupid Limited expects Q1 FY27 revenue to exceed ₹150 Cr, marking a record quarterly performance compared to ₹59.8 Cr in Q1 FY26. Management has raised its full-year FY27 revenue guidance by 10% to ₹660+ Cr, which represents an 85% growth over the TTM revenue of ₹357 Cr. This growth is supported by the upcoming operationalization of the Palava manufacturing facility in Q2 FY27 and a new long-term supply agreement with PFSCM, Netherlands. Profit margins are expected to exceed current guidance, aided by favorable USD-INR realizations and pricing trends.
Confidence: HIGH
What changedManagement has officially increased its annual revenue guidance and provided a specific, record-breaking revenue target for the first quarter of FY27.
Why it mattersThe upward revision indicates strong order visibility and successful scaling of new capacities, suggesting the company is on track to nearly double its annual revenue compared to TTM levels.
Q1 FY27 Revenue Target: ₹150 Cr+Revised FY27 Revenue Guidance: ₹660+ CrGuidance vs TTM Revenue: 184.8%Male Condom Capacity Addition: 770 million unitsFemale Condom Capacity Addition: 75 million units
📅 Short termThe stock may react positively to the guidance upgrade and the anticipation of a record-breaking Q1 performance.
📈 Long termThe 1.5x capacity expansion at Palava and diversification into IVD kits and FMCG represent a structural shift toward a larger-scale consumer wellness business.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- USD/INR volatility affecting 52% of export revenue
- Raw material inflation (latex and silicon oil)
- Execution risk in operationalizing the new Palava facility
Key Highlights
Projected Q1 FY27 revenue of ₹150 Cr+ exceeds the previous high of ₹120 Cr in Mar 2026
FY27 revenue guidance revised upward by 10% from ₹600 Cr to ₹660+ Cr
Palava facility to operationalize in Q2 FY27, adding 770 million male and 75 million female condom capacity
Commenced long-term supply agreement with PFSCM, Netherlands, to boost international B2B revenue
Company maintains a presence in 125+ countries with WHO/UNFPA pre-qualifications
👀 What to Watch
Watch for the actual Q1 FY27 financial results to confirm the ₹150 Cr revenue target and monitor the successful commissioning of the Palava facility in the next quarter.
Promoter Aditya Kumar Halwasiya acquires 21 lakh shares of Cupid Ltd via open market
Mr. Aditya Kumar Halwasiya, the Promoter, Chairman, and Managing Director of Cupid Limited, has acquired 21,00,000 equity shares of the company through an open market purchase on June 3, 2026. This acquisition increases his personal stake from 33.13% to 33.29%. Following this transaction, the total promoter and promoter group shareholding has risen to 46.24%. Such open market purchases by the CMD typically signal strong management confidence in the company's intrinsic value and future growth.
Key Highlights
Acquisition of 21,00,000 equity shares representing approximately 0.16% of the company's capital.
Transaction was executed in the open market by CMD Aditya Kumar Halwasiya.
Individual promoter holding increased from 44,55,25,475 shares (33.13%) to 44,76,25,475 shares (33.29%).
Total Promoter and Promoter Group holding reached 46.24% post-acquisition.
The acquisition was based on a face value of Re. 1/- per equity share.
👀 What to Watch
Investors should take this as a positive signal of promoter commitment and confidence. It may be worth monitoring the stock for further accumulation or potential growth catalysts that the management anticipates.
Promoter Aditya Kumar Halwasiya acquires 26 lakh shares of Cupid Ltd via open market
Aditya Kumar Halwasiya, the Promoter, Chairman, and Managing Director of Cupid Limited, has increased his stake in the company by acquiring 26,00,000 equity shares. This acquisition was conducted through the open market, representing approximately 0.19% of the total share capital. Following this transaction, the total promoter and promoter group holding has risen from 45.89% to 46.08%. Such open market purchases by top leadership are generally interpreted as a strong sign of confidence in the company's future performance.
Key Highlights
Acquisition of 26,00,000 equity shares (0.19% stake) by Promoter Aditya Kumar Halwasiya.
The transaction was executed in the open market on June 2, 2026.
Individual holding of Aditya Kumar Halwasiya increased from 32.94% to 33.13% of the total voting capital.
Total Promoter and Promoter Group holding increased to 46.08% from 45.89%.
The company's total paid-up capital consists of 134,46,60,700 equity shares of Re. 1 each.
👀 What to Watch
Investors should view this increase in promoter stake as a positive indicator of management's commitment and confidence in the company's valuation. It may be an opportune time to maintain or increase positions, while continuing to monitor quarterly earnings.
Cupid Ltd Reports Record FY26 Revenue of ₹358 Cr; Targets ₹600 Cr in FY27
Cupid Limited delivered its strongest-ever performance in FY26, with revenue reaching ₹358 Cr and net profit at ₹108 Cr, surpassing its annual guidance. The company is aggressively expanding into the FMCG space, targeting ₹150 Cr incremental revenue in FY27 through its strategic investment in Baazar Style Retail. Management has provided a robust growth outlook, aiming for ₹1,150 Cr revenue by FY29 with net margins above 30%. The shift towards a dual B2B-B2C model and the introduction of high-margin nitrile female condoms are key growth drivers.
Key Highlights
FY26 revenue grew to ₹358 Cr with a net profit of ₹108 Cr, exceeding previous guidance of ₹335 Cr and ₹100 Cr respectively.
Q4 FY26 saw massive YoY growth with revenue up 94.91% and net profit up 215.03%.
Strategic investment of ₹331.53 Cr in Baazar Style Retail provides access to 260+ stores, scaling to 500+ in 3 years.
Ambitious FY27 guidance set at ₹600 Cr revenue and ₹180 Cr net profit with margins above 30%.
Company is now the only Indian manufacturer with dual-polymer capability for both latex and nitrile condoms.
👀 What to Watch
Investors should monitor the execution of the FMCG scale-up and the integration with Baazar Style Retail, as these are pivotal for achieving the ambitious FY27-FY29 growth targets. The stock remains attractive for those looking at a high-margin healthcare and wellness play with a strong export base.
Cupid Ltd FY26 Net Profit Surges 165% to ₹108 Cr; Sets Aggressive FY27 Revenue Target of ₹600 Cr
Cupid Limited reported an exceptional FY26 performance, with total income rising 93% YoY to ₹391.40 Cr and net profit jumping 165% to ₹108.23 Cr, surpassing its previous guidance. The company's Q4 FY26 was its strongest ever, with a 215% YoY increase in net profit to ₹36.26 Cr. Management has issued a robust growth outlook, targeting ₹600 Cr revenue in FY27 and ₹1,150 Cr by FY29. The growth is underpinned by a ₹331.53 Cr strategic investment in Baazar Style Retail to bolster FMCG distribution and the development of high-margin nitrile female condoms.
Key Highlights
FY26 Net Profit grew 165% YoY to ₹108.23 Cr on a 93% increase in Total Income to ₹391.40 Cr.
Surpassed FY26 guidance of ₹335 Cr revenue and ₹100 Cr net profit through strong execution.
Strategic investment of ₹331.53 Cr in Baazar Style Retail to leverage 250+ stores for FMCG growth.
Management targets FY27 revenue of ₹600 Cr and net profit of ₹180 Cr, implying 30% net margins.
Expanding capacity to 1.25 billion male condoms and 125 million female condoms annually.
👀 What to Watch
The company is successfully transitioning from a B2B player to a diversified FMCG and healthcare brand with high growth visibility. Investors should monitor the execution of the Style Baazar integration and the scale-up of the new nitrile condom segment.
Cupid Ltd FY26 Revenue Doubles to ₹357.7 Cr; Strategic Investment in Baazar Style Retail
Cupid Limited reported a massive surge in financial performance for FY26, with annual revenue from operations jumping 95% to ₹357.71 crore from ₹183.52 crore in FY25. The Q4 FY26 revenue also saw a significant increase of 112% YoY, reaching ₹119.96 crore. Beyond earnings, the company executed a strategic move by converting 15 lakh warrants into equity shares of Baazar Style Retail Limited for ₹36.93 crore. The board also oversaw a management transition in the compliance department and appointed new internal auditors for a three-year term.
Key Highlights
Annual Revenue from operations grew 95% YoY to ₹357.71 crore in FY26.
Q4 FY26 Revenue increased 112% YoY to ₹119.96 crore compared to ₹56.48 crore in Q4 FY25.
Invested ₹36.93 crore to convert 15,00,000 warrants into equity shares of Baazar Style Retail Limited.
Appointed R. Thakkar & Associates as Internal Auditors for a 3-year period starting FY27.
Mr. Hardik Chandra appointed as Company Secretary and Compliance Officer effective May 16, 2026.
👀 What to Watch
The exceptional revenue growth and strategic diversification into retail via Baazar Style warrants suggest a strong expansionary phase; investors should hold while monitoring if the bottom-line growth keeps pace with the top-line surge.
Cupid Limited Receives SEBI Administrative Warning for Disclosure Non-Compliance
Cupid Limited has received an administrative warning letter from SEBI dated April 23, 2026, regarding a violation of Regulation 30(7) of the SEBI (LODR) Regulations, 2015. The warning was issued due to the company's failure to disclose material information concerning the cancellation of a preferential issue. Although the company states there is no material impact on its financials or operations, the letter highlights a lapse in corporate governance and timely disclosure. The company has expressed its commitment to maintaining higher standards of regulatory adherence in the future.
Key Highlights
SEBI issued an administrative warning letter on April 23, 2026, received by the company on April 28, 2026.
The warning pertains to the non-disclosure of the cancellation of a preferential issue, violating Regulation 30(7).
Management confirms that the warning does not have a quantifiable monetary impact on current financials or operations.
The company is required to place the warning letter before its Board of Directors and take corrective measures.
👀 What to Watch
Investors should view this as a minor governance lapse and monitor if the company improves its disclosure transparency moving forward. No immediate financial impact is expected, but repeated regulatory warnings could signal deeper internal control issues.
Cupid Limited Invests ₹82.88 Cr in Baazar Style Retail to Boost FMCG Reach
Cupid Limited has completed the first phase of its strategic investment in Baazar Style Retail Limited, deploying ₹82.88 crore out of a total planned ₹331.53 crore. This investment, made via 1.01 crore warrants, provides Cupid direct access to over 260 retail stores for its expanding FMCG and wellness portfolio. The company expects this partnership to generate an incremental annual revenue of ₹500 crore within the next three years. This move aligns with Cupid's strategy to pivot from a pure-play manufacturer to a consumer-facing FMCG brand.
Key Highlights
Deployed ₹82.88 crore as 25% of a total ₹331.53 crore strategic investment plan
Allotted 1,01,00,000 warrants convertible into equity shares of Baazar Style Retail Limited
Gains immediate access to 260+ stores, with the retail partner planning expansion to 500+ stores
Management projects ₹500 crore in incremental annual revenue within 3 years from this partnership
👀 What to Watch
Investors should view this as a significant step in Cupid's transformation into an FMCG player; monitor the quarterly revenue contribution from the retail segment to validate the ₹500 crore guidance.
Cupid Ltd to Invest Rs 331.5 Cr in Baazar Style Retail via 1.01 Cr Warrants
Cupid Limited has committed to a strategic investment in Baazar Style Retail Limited by subscribing to 1,01,00,000 convertible warrants at Rs 328.25 per warrant. The company has already paid the 25% upfront amount of Rs 82.88 crore, with the remaining 75% payable upon conversion into equity. This partnership provides Cupid access to Baazar Style's network of 250+ stores, which is expected to double to 500+ stores within three years. The target company is a growing fashion retailer with a FY25 turnover of Rs 1,343.71 crore.
Key Highlights
Acquisition of 1,01,00,000 warrants at Rs 328.25 each, totaling approximately Rs 331.53 crore.
Upfront payment of Rs 82.88 crore (25%) already completed by Cupid Limited.
Strategic access to 250+ existing retail stores to scale Cupid's FMCG product portfolio.
Target company Baazar Style Retail reported FY25 revenue of Rs 1,343.71 crore and PAT of Rs 14.66 crore.
Baazar Style aims to expand its retail footprint to over 500 locations within the next 3 years.
👀 What to Watch
Investors should monitor the successful integration of Cupid's products into the Baazar Style retail network as a key driver for FMCG segment growth. This move signals a significant shift towards a direct-to-consumer retail strategy.
Cupid Ltd to Surpass FY26 Guidance; Targets ₹600 Cr Revenue and 30%+ PAT Margin in FY27
Cupid Limited has announced that it is set to deliver its strongest quarterly performance ever, comfortably exceeding its FY26 guidance of ₹335 crore in revenue and ₹100 crore in net profit. Looking ahead, the company has provided a robust outlook for FY27, targeting a minimum revenue of ₹600 crore and net profit margins exceeding 30%. This growth is underpinned by a 1.5x capacity expansion and strong export traction across 125 countries. Additionally, the company has secured raw material visibility for the next six months, mitigating risks from crude-derived input costs.
Key Highlights
Exceeding FY26 annual guidance of ₹335 Cr revenue and ₹100 Cr net profit.
Aggressive FY27 revenue target of at least ₹600 Cr with net profit margins > 30%.
Production capacity increased 1.5x to 770 million male and 75 million female condoms annually.
Raw material inventory secured for 6 months with favorable USD-INR export tailwinds.
Strong global presence as the first company with WHO/UNFPA pre-qualification for both condom types.
👀 What to Watch
The significant upward revision in FY27 guidance and strong margin profile suggest a high-growth trajectory; investors should monitor the upcoming formal Q4 results for execution consistency.
Cupid Promoter Aditya Kumar Halwasiya Acquires 8 Lakh Shares via Open Market
Mr. Aditya Kumar Halwasiya, the Promoter, Chairman, and Managing Director of Cupid Limited, has acquired 8,00,000 equity shares of the company through an open market purchase. This transaction, dated March 20, 2026, represents approximately 0.06% of the company's total share capital. Following this acquisition, his personal stake has increased from 32.84% to 32.90%. The total promoter and promoter group holding now stands at 45.85%, up from 45.79%.
Key Highlights
Acquisition of 8,00,000 equity shares (0.06% stake) via open market purchase
Promoter Aditya Kumar Halwasiya's individual holding increased from 32.84% to 32.90%
Total Promoter and Promoter Group holding rose to 45.85% from 45.79%
The transaction was executed on March 20, 2026, as per the SEBI (SAST) disclosure
👀 What to Watch
Investors should view this open market purchase by the CMD as a positive signal of management's confidence in the company's future prospects. It suggests that the leadership perceives the current market price as attractive or undervalued.
Cupid Limited Aligns with Japanese Quality Standards via Strategic Partnership
Cupid Limited has announced a strategic branding alignment, 'Made in India' with 'Japanese Quality,' through a collaboration with Asia’s oldest latex condom manufacturer. This move is designed to enhance technological capabilities and boost confidence among global OEM partners and retail consumers. The company currently exports to over 125 countries and holds unique WHO/UNFPA pre-qualifications. This initiative complements their recent capacity expansion, which added 770 million male condoms to their annual output.
Key Highlights
Collaboration with Asia’s oldest latex condom manufacturer to adopt 'Japanese Quality' standards.
Strategic focus on 125+ export markets and global OEM partnership growth.
Leverages 28 years of manufacturing expertise to improve product precision and reliability.
Follows a 1.5x capacity expansion, adding 770 million male and 75 million female condoms annually.
👀 What to Watch
This move strengthens Cupid's competitive positioning in the premium and OEM segments; investors should watch for improved margins and new international contracts resulting from this quality upgrade.
Cupid Ltd Announces Strategic Branding Alignment with Japanese Quality Standards
Cupid Limited has entered into a strategic collaboration with Asia's oldest latex condom manufacturer to adopt 'Japanese Quality' standards for its 'Made in India' products. This initiative aims to bolster consumer trust and strengthen relationships with global OEM partners across 125 countries. The branding shift coincides with a significant capacity expansion at its Palava facility, which is set to add 770 million male and 75 million female condoms annually, representing a 1.5x increase in production. This move is designed to leverage the company's 28-year manufacturing heritage to capture higher market share in the premium wellness segment.
Key Highlights
Collaboration with Asia's oldest latex manufacturer to integrate Japanese precision and quality standards.
Ongoing capacity expansion to add 770 million male and 75 million female condoms annually (1.5x growth).
Global footprint spanning over 125 countries with existing WHO and UNFPA pre-qualifications.
Strategic focus on premiumization to enhance appeal for both retail consumers and global OEM partners.
👀 What to Watch
Investors should monitor the impact of this premium branding on export margins and the company's ability to secure higher-value OEM contracts. The successful integration of Japanese quality standards could serve as a key differentiator in the competitive global wellness market.
Cupid Ltd Allots 107.57 Cr Bonus Shares; Paid-up Capital Rises to Rs 134.47 Cr
Cupid Limited has finalized the allotment of 1,07,57,28,560 bonus equity shares to eligible shareholders as of the record date, March 9, 2026. The bonus issue was executed in a 4:1 ratio, providing four new shares for every one existing share held. This corporate action has significantly increased the company's paid-up share capital from Rs 26.89 crore to Rs 134.47 crore. The new shares will rank pari-passu with existing shares and are expected to enhance the stock's liquidity in the market.
Key Highlights
Allotment of 1,07,57,28,560 bonus equity shares with a face value of Re. 1 each
Bonus issue ratio maintained at 4:1 (4 new shares for every 1 existing share)
Total paid-up share capital increased from Rs 26,89,32,140 to Rs 134,46,60,700
Record date for eligibility was March 9, 2026, with allotment approved on March 10, 2026
New shares will rank pari-passu in all respects with existing equity shares
👀 What to Watch
Investors should monitor their demat accounts for the credit of bonus shares and note the proportional adjustment in the stock price. No further action is required as the total investment value remains fundamentally unchanged despite the increased share count.
